93EGP
- Active ingredient
- glimepiride+pioglitazone
- Strength
- 2/30 mg
- Form
- tablet
- Manufacturer
- eva pharma
- Route
- oral.solid
Uses
Used with diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Do not use if
Contraindicated in patients with hypersensitivity to components and in initiation of treatment for NYHA class III or IV heart failure.
Side effects
Hypoglycemia, weight gain, edema, headache, and upper respiratory symptoms may occur. Heart failure risk may increase.
Warnings
Monitor for heart failure, hypoglycemia, edema, and weight gain. Regular glucose monitoring is important.
How it works
Combines a sulfonylurea that stimulates insulin secretion with a thiazolidinedione that improves insulin sensitivity.
Storage
Store at 15–30°C in a tightly closed container protected from moisture.